Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPIAO vs EPREX in CKD Related Anaemia
NCT02522975Phase 4Terminated
- Sponsor
- 3SBio
- Start
- Aug 2015
- Primary completion
- Jun 2019
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 4 trial of epoetin alfa in anemia of chronic kidney disease (CKD-A), sponsored by 3SBio. Started Aug 2015; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02522975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02522975.